Repurposing memantine as an oral therapy for visceral leishmaniasis: identification of direct leishmanicidal activity and immune system modulation in preclinical studies.

Front Pharmacol · 2026 · PMC13070929 · PMID 41982664

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

Similarly, in the long-term scheme, a clear trend of dose-related efficacy was observed, with the lowest dose (1.5 mg/kg/day) being less effective than the intermediate and highest doses.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.